Johnson & Johnson will stop selling drug-coated heart stents, a former profit driver for the diversified healthcare company that has stumbled due to safety concerns and fierce competition from rival ...

NEW YORK (Reuters) - Johnson & Johnson will stop selling drug-coated heart stents, a former profit driver for the diversified healthcare company that has stumbled due to safety concerns and fierce ...

Last week’s news that J&J is abandoning their coronary stent business was sad, but provided several lessons about poor product development execution and the need for constant innovation. J&J created ...

Johnson & Johnson's (JNJ) announcement that it is getting out of the drug-eluting stent business-- those are the tiny drug-covered tubes inserted into arteries to prevent strokes -- was blamed by many ...